Europe Liver Disease Drug Sales Market Report 2021

August 2016 | 124 pages | ID: E899FED4D98EN
QYResearch

Abstracts

This report studies sales (consumption) of Liver Disease Drug in Europe market, especially in Germany, UK, France, Italy, Spain and Russia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Bayer Schering AG
• Biotest
• Bristol-Myers Squibb
• Eli Lilly
• Glaxosmithkline PlC
• Merck & Co
• Pfizer
• Roche
• Valeant Pharmaceuticals International, Inc
• Chia Tai Tianqing Pharmaceutical Group
• Fujian Cosunter Pharmaceutical Company
• Beijing Sl Pharmaceutical Co., Ltd.
• Inner Mongolia Furui Medical Science Co. Ltd.

Market Segment by Regions, this report splits Europe into several key Regions, with sales (consumption), revenue, market share and growth rate of Liver Disease Drug in these regions, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Italy
• Spain
• Russia

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Liver Disease Drug in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

1 LIVER DISEASE DRUG OVERVIEW

1.1 Product Overview and Scope of Liver Disease Drug
1.2 Classification of Liver Disease Drug
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Applications of Liver Disease Drug
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Liver Disease Drug Market by Regions
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Italy Status and Prospect (2011-2021)
  1.4.5 Spain Status and Prospect (2011-2021)
  1.4.6 Russia Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Liver Disease Drug (2011-2021)
  1.5.1 Europe Liver Disease Drug Sales, Revenue and Price (2011-2021)
  1.5.2 Europe Liver Disease Drug Sales and Growth Rate (2011-2021)
  1.5.3 Europe Liver Disease Drug Revenue and Growth Rate (2011-2021)

2 EUROPE LIVER DISEASE DRUG BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Liver Disease Drug Market Competition by Manufacturers
  2.1.1 Europe Liver Disease Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Liver Disease Drug Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Liver Disease Drug (Volume and Value) by Type
  2.2.1 Europe Liver Disease Drug Sales and Market Share by Type (2011-2021)
  2.2.2 Europe Liver Disease Drug Revenue and Market Share by Type (2011-2021)
2.3 Europe Liver Disease Drug (Volume and Value) by Regions
  2.3.1 Europe Liver Disease Drug Sales and Market Share by Regions (2011-2021)
  2.3.2 Europe Liver Disease Drug Revenue and Market Share by Regions (2011-2021)
2.4 Europe Liver Disease Drug (Volume) by Application

3 GERMANY LIVER DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Liver Disease Drug Sales and Value (2011-2021)
  3.1.1 Germany Liver Disease Drug Sales and Growth Rate (2011-2021)
  3.1.2 Germany Liver Disease Drug Revenue and Growth Rate (2011-2021)
  3.1.3 Germany Liver Disease Drug Sales Price Trend (2011-2021)
3.2 Germany Liver Disease Drug Sales and Market Share by Manufacturers
3.3 Germany Liver Disease Drug Sales and Market Share by Type
3.4 Germany Liver Disease Drug Sales and Market Share by Applications

4 UK LIVER DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 UK Liver Disease Drug Sales and Value (2011-2021)
  4.1.1 UK Liver Disease Drug Sales and Growth Rate (2011-2021)
  4.1.2 UK Liver Disease Drug Revenue and Growth Rate (2011-2021)
  4.1.3 UK Liver Disease Drug Sales Price Trend (2011-2021)
4.2 UK Liver Disease Drug Sales and Market Share by Manufacturers
4.3 UK Liver Disease Drug Sales and Market Share by Type
4.4 UK Liver Disease Drug Sales and Market Share by Applications

5 FRANCE LIVER DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 France Liver Disease Drug Sales and Value (2011-2021)
  5.1.1 France Liver Disease Drug Sales and Growth Rate (2011-2021)
  5.1.2 France Liver Disease Drug Revenue and Growth Rate (2011-2021)
  5.1.3 France Liver Disease Drug Sales Price Trend (2011-2021)
5.2 France Liver Disease Drug Sales and Market Share by Manufacturers
5.3 France Liver Disease Drug Sales and Market Share by Type
5.4 France Liver Disease Drug Sales and Market Share by Applications

6 ITALY LIVER DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Italy Liver Disease Drug Sales and Value (2011-2021)
  6.1.1 Italy Liver Disease Drug Sales and Growth Rate (2011-2021)
  6.1.2 Italy Liver Disease Drug Revenue and Growth Rate (2011-2021)
  6.1.3 Italy Liver Disease Drug Sales Price Trend (2011-2021)
6.2 Italy Liver Disease Drug Sales and Market Share by Manufacturers
6.3 Italy Liver Disease Drug Sales and Market Share by Type
6.4 Italy Liver Disease Drug Sales and Market Share by Applications

7 RUSSIA LIVER DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 Russia Liver Disease Drug Sales and Value (2011-2021)
  7.1.1 Russia Liver Disease Drug Sales and Growth Rate (2011-2021)
  7.1.2 Russia Liver Disease Drug Revenue and Growth Rate (2011-2021)
  7.1.3 Russia Liver Disease Drug Sales Price Trend (2011-2021)
7.2 Russia Liver Disease Drug Sales and Market Share by Manufacturers
7.3 Russia Liver Disease Drug Sales and Market Share by Type
7.4 Russia Liver Disease Drug Sales and Market Share by Applications

8 SPAIN LIVER DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Liver Disease Drug Sales and Value (2011-2021)
  8.1.1 Spain Liver Disease Drug Sales and Growth Rate (2011-2021)
  8.1.2 Spain Liver Disease Drug Revenue and Growth Rate (2011-2021)
  8.1.3 Spain Liver Disease Drug Sales Price Trend (2011-2021)
8.2 Spain Liver Disease Drug Sales and Market Share by Manufacturers
8.3 Spain Liver Disease Drug Sales and Market Share by Type
8.4 Spain Liver Disease Drug Sales and Market Share by Applications

9 EUROPE LIVER DISEASE DRUG MANUFACTURERS ANALYSIS

9.1 Bayer Schering AG
  9.1.1 Company Basic Information,Manufacturing Base and Competitors
  9.1.2 Liver Disease Drug Product Type and Technology
    9.1.2.1 Type I
    9.1.2.2 Type II
  9.1.3 Liver Disease Drug Sales, Revenue, Price of Bayer Schering AG (2015 and 2016)
9.2 Biotest
  9.2.1 Company Basic Information,Manufacturing Base and Competitors
  9.2.2 Liver Disease Drug Product Type and Technology
    9.2.2.1 Type I
    9.2.2.2 Type II
  9.2.3 Liver Disease Drug Sales, Revenue, Price of Biotest (2015 and 2016)
9.3 Bristol-Myers Squibb
  9.3.1 Company Basic Information,Manufacturing Base and Competitors
  9.3.2 Liver Disease Drug Product Type and Technology
    9.3.2.1 Type I
    9.3.2.2 Type II
  9.3.3 Liver Disease Drug Sales, Revenue, Price of Bristol-Myers Squibb (2015 and 2016)
9.4 Eli Lilly
  9.4.1 Company Basic Information,Manufacturing Base and Competitors
  9.4.2 Liver Disease Drug Product Type and Technology
    9.4.2.1 Type I
    9.4.2.2 Type II
  9.4.3 Liver Disease Drug Sales, Revenue, Price of Eli Lilly (2015 and 2016)
9.5 Glaxosmithkline PlC
  9.5.1 Company Basic Information,Manufacturing Base and Competitors
  9.5.2 Liver Disease Drug Product Type and Technology
    9.5.2.1 Type I
    9.5.2.2 Type II
  9.5.3 Liver Disease Drug Sales, Revenue, Price of Glaxosmithkline PlC (2015 and 2016)
9.6 Merck & Co
  9.6.1 Company Basic Information,Manufacturing Base and Competitors
  9.6.2 Liver Disease Drug Product Type and Technology
    9.6.2.1 Type I
    9.6.2.2 Type II
  9.6.3 Liver Disease Drug Sales, Revenue, Price of Merck & Co (2015 and 2016)
9.7 Pfizer
  9.7.1 Company Basic Information,Manufacturing Base and Competitors
  9.7.2 Liver Disease Drug Product Type and Technology
    9.7.2.1 Type I
    9.7.2.2 Type II
  9.7.3 Liver Disease Drug Sales, Revenue, Price of Pfizer (2015 and 2016)
9.8 Roche
  9.8.1 Company Basic Information,Manufacturing Base and Competitors
  9.8.2 Liver Disease Drug Product Type and Technology
    9.8.2.1 Type I
    9.8.2.2 Type II
  9.8.3 Liver Disease Drug Sales, Revenue, Price of Roche (2015 and 2016)
9.9 Valeant Pharmaceuticals International, Inc
  9.9.1 Company Basic Information,Manufacturing Base and Competitors
  9.9.2 Liver Disease Drug Product Type and Technology
    9.9.2.1 Type I
    9.9.2.2 Type II
  9.9.3 Liver Disease Drug Sales, Revenue, Price of Valeant Pharmaceuticals International, Inc (2015 and 2016)
9.10 Chia Tai Tianqing Pharmaceutical Group
  9.10.1 Company Basic Information,Manufacturing Base and Competitors
  9.10.2 Liver Disease Drug Product Type and Technology
    9.10.2.1 Type I
    9.10.2.2 Type II
  9.10.3 Liver Disease Drug Sales, Revenue, Price of Chia Tai Tianqing Pharmaceutical Group (2015 and 2016)
9.11 Fujian Cosunter Pharmaceutical Company
  9.11.1 Company Basic Information,Manufacturing Base and Competitors
  9.11.2 Liver Disease Drug Product Type and Technology
    9.11.2.1 Type I
    9.11.2.2 Type II
  9.11.3 Liver Disease Drug Sales, Revenue, Price of Fujian Cosunter Pharmaceutical Company (2015 and 2016)
9.12 Beijing Sl Pharmaceutical Co., Ltd.
  9.12.1 Company Basic Information,Manufacturing Base and Competitors
  9.12.2 Liver Disease Drug Product Type and Technology
    9.12.2.1 Type I
    9.12.2.2 Type II
  9.12.3 Liver Disease Drug Sales, Revenue, Price of Beijing Sl Pharmaceutical Co., Ltd. (2015 and 2016)
9.13 Inner Mongolia Furui Medical Science Co. Ltd.
  9.13.1 Company Basic Information,Manufacturing Base and Competitors
  9.13.2 Liver Disease Drug Product Type and Technology
    9.13.2.1 Type I
    9.13.2.2 Type II
  9.13.3 Liver Disease Drug Sales, Revenue, Price of Inner Mongolia Furui Medical Science Co. Ltd. (2015 and 2016)

10 LIVER DISEASE DRUG TECHNOLOGY AND DEVELOPMENT TREND

10.1 Liver Disease Drug Technology Analysis
10.2 Liver Disease Drug Technology Development Trend

11 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Liver Disease Drug
Table Classification of Liver Disease Drug
Figure Europe Sales Market Share of Liver Disease Drug by Types in 2015
Table Applications of Liver Disease Drug
Figure Europe Sales Market Share of Liver Disease Drug by Applications in 2015
Figure Germany Liver Disease Drug Revenue and Growth Rate (2011-2021)
Figure France Liver Disease Drug Revenue and Growth Rate (2011-2021)
Figure UK Liver Disease Drug Revenue and Growth Rate (2011-2021)
Figure Italy Liver Disease Drug Revenue and Growth Rate (2011-2021)
Figure Spain Liver Disease Drug Revenue and Growth Rate (2011-2021)
Figure Russia Liver Disease Drug Revenue and Growth Rate (2011-2021)
Table Europe Liver Disease Drug Sales, Revenue and Price (2011-2021)
Figure Europe Liver Disease Drug Sales and Growth Rate (2011-2021)
Figure Europe Liver Disease Drug Revenue and Growth Rate (2011-2021)
Table Europe Liver Disease Drug Sales of Key Manufacturers (2015 and 2016)
Table Europe Liver Disease Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Liver Disease Drug Sales Share by Manufacturers
Figure 2016 Liver Disease Drug Sales Share by Manufacturers
Table Europe Liver Disease Drug Revenue by Manufacturers (2015 and 2016)
Table Europe Liver Disease Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Liver Disease Drug Revenue Share by Manufacturers
Table 2016 Europe Liver Disease Drug Revenue Share by Manufacturers
Table Europe Liver Disease Drug Sales and Market Share by Type (2011-2021)
Table Europe Liver Disease Drug Sales Share by Type (2011-2021)
Figure Sales Market Share of Liver Disease Drug by Type (2011-2021)
Figure Europe Liver Disease Drug Sales Growth Rate by Type (2011-2021)
Table Europe Liver Disease Drug Revenue and Market Share by Type (2011-2021)
Table Europe Liver Disease Drug Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Liver Disease Drug by Type (2011-2021)
Figure Europe Liver Disease Drug Revenue Growth Rate by Type (2011-2021)
Table Europe Liver Disease Drug Sales and Market Share by Regions (2011-2021)
Table Europe Liver Disease Drug Sales Share by Regions (2011-2021)
Figure Sales Market Share of Liver Disease Drug by Regions (2011-2021)
Figure Europe Liver Disease Drug Sales Growth Rate by Regions (2011-2021)
Table Europe Liver Disease Drug Revenue and Market Share by Regions (2011-2021)
Table Europe Liver Disease Drug Revenue Share by Regions (2011-2021)
Figure Revenue Market Share of Liver Disease Drug by Regions (2011-2021)
Figure Europe Liver Disease Drug Revenue Growth Rate by Regions (2011-2021)
Table Europe Liver Disease Drug Sales and Market Share by Application (2011-2021)
Table Europe Liver Disease Drug Sales Share by Application (2011-2021)
Figure Sales Market Share of Liver Disease Drug by Application (2011-2021)
Figure Europe Liver Disease Drug Sales Growth Rate by Application (2011-2021)
Figure Germany Liver Disease Drug Sales and Growth Rate (2011-2021)
Figure Germany Liver Disease Drug Revenue and Growth Rate (2011-2021)
Figure Germany Liver Disease Drug Sales Price Trend (2011-2021)
Table Germany Liver Disease Drug Sales by Manufacturers (2015 and 2016)
Table Germany Liver Disease Drug Market Share by Manufacturers (2015 and 2016)
Table Germany Liver Disease Drug Sales by Type (2015 and 2016)
Table Germany Liver Disease Drug Market Share by Type (2015 and 2016)
Table Germany Liver Disease Drug Sales by Applications (2015 and 2016)
Table Germany Liver Disease Drug Market Share by Applications (2015 and 2016)
Figure UK Liver Disease Drug Sales and Growth Rate (2011-2021)
Figure UK Liver Disease Drug Revenue and Growth Rate (2011-2021)
Figure UK Liver Disease Drug Sales Price Trend (2011-2021)
Table UK Liver Disease Drug Sales by Manufacturers (2015 and 2016)
Table UK Liver Disease Drug Market Share by Manufacturers (2015 and 2016)
Table UK Liver Disease Drug Sales by Type (2015 and 2016)
Table UK Liver Disease Drug Market Share by Type (2015 and 2016)
Table UK Liver Disease Drug Sales by Applications (2015 and 2016)
Table UK Liver Disease Drug Market Share by Applications (2015 and 2016)
Figure France Liver Disease Drug Sales and Growth Rate (2011-2021)
Figure France Liver Disease Drug Revenue and Growth Rate (2011-2021)
Figure France Liver Disease Drug Sales Price Trend (2011-2021)
Table France Liver Disease Drug Sales by Manufacturers (2015 and 2016)
Table France Liver Disease Drug Market Share by Manufacturers (2015 and 2016)
Table France Liver Disease Drug Sales by Type (2015 and 2016)
Table France Liver Disease Drug Market Share by Type (2015 and 2016)
Table France Liver Disease Drug Sales by Applications (2015 and 2016)
Table France Liver Disease Drug Market Share by Applications (2015 and 2016)
Figure Italy Liver Disease Drug Sales and Growth Rate (2011-2021)
Figure Italy Liver Disease Drug Revenue and Growth Rate (2011-2021)
Figure Italy Liver Disease Drug Sales Price Trend (2011-2021)
Table Italy Liver Disease Drug Sales by Manufacturers (2015 and 2016)
Table Italy Liver Disease Drug Market Share by Manufacturers (2015 and 2016)
Table Italy Liver Disease Drug Sales by Type (2015 and 2016)
Table Italy Liver Disease Drug Market Share by Type (2015 and 2016)
Table Italy Liver Disease Drug Sales by Applications (2015 and 2016)
Table Italy Liver Disease Drug Market Share by Applications (2015 and 2016)
Figure Russia Liver Disease Drug Sales and Growth Rate (2011-2021)
Figure Russia Liver Disease Drug Revenue and Growth Rate (2011-2021)
Figure Russia Liver Disease Drug Sales Price Trend (2011-2021)
Table Russia Liver Disease Drug Sales by Manufacturers (2015 and 2016)
Table Russia Liver Disease Drug Market Share by Manufacturers (2015 and 2016)
Table Russia Liver Disease Drug Sales by Type (2015 and 2016)
Table Russia Liver Disease Drug Market Share by Type (2015 and 2016)
Table Russia Liver Disease Drug Sales by Applications (2015 and 2016)
Table Russia Liver Disease Drug Market Share by Applications (2015 and 2016)
Figure Spain Liver Disease Drug Sales and Growth Rate (2011-2021)
Figure Spain Liver Disease Drug Revenue and Growth Rate (2011-2021)
Figure Spain Liver Disease Drug Sales Price Trend (2011-2021)
Table Spain Liver Disease Drug Sales by Manufacturers (2015 and 2016)
Table Spain Liver Disease Drug Market Share by Manufacturers (2015 and 2016)
Table Spain Liver Disease Drug Sales by Type (2015 and 2016)
Table Spain Liver Disease Drug Market Share by Type (2015 and 2016)
Table Spain Liver Disease Drug Sales by Applications (2015 and 2016)
Table Spain Liver Disease Drug Market Share by Applications (2015 and 2016)
Table Bayer Schering AG Basic Information List
Table Liver Disease Drug Sales, Revenue, Price of Bayer Schering AG (2015 and 2016)
Table Biotest Basic Information List
Table Liver Disease Drug Sales, Revenue, Price of Biotest (2015 and 2016)
Table Bristol-Myers Squibb Basic Information List
Table Liver Disease Drug Sales, Revenue, Price of Bristol-Myers Squibb (2015 and 2016)
Table Eli Lilly Basic Information List
Table Liver Disease Drug Sales, Revenue, Price of Eli Lilly (2015 and 2016)
Table Glaxosmithkline PlC Basic Information List
Table Liver Disease Drug Sales, Revenue, Price of Glaxosmithkline PlC (2015 and 2016)
Table Merck & Co Basic Information List
Table Liver Disease Drug Sales, Revenue, Price of Merck & Co (2015 and 2016)
Table Pfizer Basic Information List
Table Liver Disease Drug Sales, Revenue, Price of Pfizer (2015 and 2016)
Table Roche Basic Information List
Table Liver Disease Drug Sales, Revenue, Price of Roche (2015 and 2016)
Table Valeant Pharmaceuticals International, Inc Basic Information List
Table Liver Disease Drug Sales, Revenue, Price of Valeant Pharmaceuticals International, Inc (2015 and 2016)
Table Chia Tai Tianqing Pharmaceutical Group Basic Information List
Table Liver Disease Drug Sales, Revenue, Price of Chia Tai Tianqing Pharmaceutical Group (2015 and 2016)